Maven Securities LTD Seagen Inc. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $49.8 Million - $56.2 Million	260,100 Added 765.0%	294,100 $62.4 Million
Q2 2023 Aug 04, 2023	BUY	$187.64 - $206.25 $5.91 Million - $6.5 Million	31,500 Added 1260.0%	34,000 $6.54 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $318,975 - $507,700	2,500 New	2,500 $506,000
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $183,843 - $219,257	-1,361 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $187,151 - $259,678	1,361 New	1,361 $189,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.